Hormone replacement therapy: benefits and risks for the general postmenopausal female population and for women with a history of previously treated breast cancer.
作者信息
Bluming A Z
机构信息
Hematology Oncology Medical Group of the San Fernando Valley, Encino, CA 91436.
出版信息
Semin Oncol. 1993 Dec;20(6):662-74.
PMID:8296203
Abstract
摘要
相似文献
1
2
[Benefits and risks in hormone substitute therapy in postmenopause].
Srp Arh Celok Lek. 1996 May-Jun;124(5-6):143-6.
3
[Menopause and hormone therapy].[绝经与激素治疗]
Rev Med Suisse Romande. 1989 Nov;109(11):885-7.
4
Hormone replacement therapy and the menopause. Australian Menopause Society.激素替代疗法与更年期。澳大利亚更年期协会。
Med J Aust. 1991 Jul 1;155(1):43-4.
5
[Benefits and risks of postmenopausal hormone replacement therapy. Symptoms improved but not a better outcome?].[绝经后激素替代疗法的益处与风险。症状改善但结局未更佳？]
MMW Fortschr Med. 2010 Jun 17;152(24):18.
6
Friedan and estrogen: 'most unfortunate that she is so misinformed'.弗里丹与雌激素：“她被误导得如此严重，真是太不幸了”。
Geriatrics. 1994 Mar;49(3):11.
7
Weighing the risks and benefits of hormone therapy.权衡激素疗法的风险与益处。
JAAPA. 2003 Jun;16(6):45-7.
8
9
[Hormone replacement therapy following breast carcinoma].[乳腺癌后的激素替代疗法]
Ned Tijdschr Geneeskd. 1998 Jan 17;142(3):113-7.
10
[Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy].[选择性雌激素受体调节剂（SERM）：激素替代疗法的新物质]
Schweiz Med Wochenschr. 1999 Dec 11;129(49):1926-30.
引用本文的文献
1
Postmenopausal syndrome.绝经后综合征
Indian J Psychiatry. 2015 Jul;57(Suppl 2):S222-32. doi: 10.4103/0019-5545.161483.
Zotero 插件